Hampton Receives $1.3 Million Grant to Develop Drug Treatment for Lung Cancer
Hampton University yesterday announced its receipt of a $1.35 million, five-year grant from the National Institutes of Health to develop drug treatment for lung cancer. It is the second multimillion dollar grant awarded from NIH to the HU School of Pharmacy’s Department of Pharmaceutical Sciences in two years.
“Given the lack of a viable therapeutic agent against lung cancer, we aim to address this unmet medical need by synthesizing novel drug entities using a combinatorial approach involving structural bioinformatics, synthetic chemistry and molecular biology techniques,” (Hampton assistant professor of pharmaceutical sciences Anand) Iyer said. “The ultimate goal is to engineer a suitable drug candidate that can effectively target lung cancer, with an eventual goal to conduct clinical trials.”